Skip to main content
AJNR: American Journal of Neuroradiology logoLink to AJNR: American Journal of Neuroradiology
. 1983 May-Jun;4(3):848-50.

Iopamidol and metrizamide in cervical myelography: side effects, EEG, and CSF changes.

L Moschini, O Manara, G Bonaldi, V Cassinari, N Quilici, G Belloni
PMCID: PMC8335013  PMID: 6410870

Abstract

Two nonionic contrast media, iopamidol and metrizamide (Amipaque), were used for cervical myelography (C1-C2 puncture) in 95 consecutive patients. Both contrast media gave excellent radiographic results. Headache and vagal symptoms were similar in both groups, whereas metrizamide produced more electroencephalographic changes and epileptic seizures. Meningeal irritation occurred in both groups and was severe in three cases. Cerebrospinal fluid showed protein and cellular changes of inflammatory type in both groups. Iopamidol is considered to be the more suitable contrast medium for cervical myelography despite its slight neurotoxicity.

Full Text

The Full Text of this article is available as a PDF (1.5 MB).


Articles from AJNR: American Journal of Neuroradiology are provided here courtesy of American Society of Neuroradiology

RESOURCES